ENDPOINTS NEWS: Maryland biotech gets green light for stem cell-derived therapy for diabetes, aiming to compete with Vertex

About Seraxis, Inc.

Seraxis is a private biotechnology company launched in 2013 and located in Germantown, Maryland. The Seraxis mission is to develop a practical and potent cell replacement therapy for insulin-dependent diabetes.